Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPBWR1 | P48145 | 2/20 | 0.66 |
| ▸ | KISS1R | Q969F8 | 16/20 | 0.66 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.63 |
| ▸ | CCKAR | P32238 | 1/20 | 0.63 |
| ▸ | CCKBR | P32239 | 1/20 | 0.63 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31141448 | 0.98 | KISS1R (0.69) | NPBWR1KISS1R | |
| SCHEMBL31141460 | 0.95 | KISS1R (0.72) | KISS1R | |
| SCHEMBL30530898 | 0.94 | KISS1R (0.71) | KISS1R | |
| SCHEMBL31141449 | 0.94 | KISS1R (0.73) | KISS1R | |
| SCHEMBL29595673 | 0.93 | GLP1R (0.64) | NPBWR1KISS1ROPRD1CCKARCCKBR | |
| SCHEMBL31141446 | 0.93 | KISS1R (0.69) | NPBWR1KISS1R | |
| Kisspeptin-10 SCHEMBL15930211 | 0.92 | KISS1R (0.77) | KISS1R | |
| Kisspeptin-10 SCHEMBL20865531 | 0.92 | KISS1R (0.77) | KISS1R | |
| SCHEMBL30530852 | 0.92 | KISS1R (0.77) | KISS1R | |
| Kisspeptin-10 SCHEMBL29376534 | 0.92 | KISS1R (0.77) | KISS1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024206577-A1 | KISSPEPTIN RECEPTOR (KISS1R) TARGETED THERAPEUTICS AND USES THEREOF | RADIONETICS ONCOLOGY, INC. (US) | 2024-10-03 | — | — | WO | claimed |
| WO-2024206577-A1 | KISSPEPTIN RECEPTOR (KISS1R) TARGETED THERAPEUTICS AND USES THEREOF | RADIONETICS ONCOLOGY, INC. (US) | 2024-10-03 | — | — | WO | disclosed |